ResearcherLevine Cancer InstituteActive in the last 2 years

Diptasree Mukherjee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8962-2759; OpenAlex author ID A5072752369. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Adjuvant multimodality immunotherapy in resected high-risk pancreatic ductal adenocarcinoma. First author DOI 10.21037/tgh-2026-0046 ↗
Risk of pancreatic cancer in individuals with celiac disease in the United States: A population-based matched cohort study. Co-author DOI 10.4251/wjgo.v15.i3.523 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Arunkumar Krishnan · 2 shared papers, 2023–2026 · strength 0.82
- Paper Adjuvant multimodality immunotherapy in resected high-risk pancreatic ductal adenocarcinoma. DOI 10.21037/tgh-2026-0046 ↗
- Paper Risk of pancreatic cancer in individuals with celiac disease in the United States: A population-based matched cohort st… DOI 10.4251/wjgo.v15.i3.523 ↗
Shyam J Thakkar · 1 shared paper, 2023 · strength 0.19
- Paper Risk of pancreatic cancer in individuals with celiac disease in the United States: A population-based matched cohort st… DOI 10.4251/wjgo.v15.i3.523 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.